Full name
FERRING PHARMACEUTICALS POLAND SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
46.46.Z - Wholesale trade of pharmaceutical and medical products
46.18.Z - Activity of agents involved in wholesale trade of other specified goods
52.10 - Warehousing and storage of goods
72.19.Z - Scientific research and development activities
73.11.Z - Advertising agency activities
73.20.Z - Market research and public opinion polling
74.90.Z - Other professional, scientific and technical activities, not elsewhere classified
82.30 - Activities related to organizing fairs, exhibitions, and congresses
82.92.Z - Packaging activities
86.90.E - Healthcare
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Assets | 47,1 | 48,6 | 60,3 | 24,2 |
Gross profit (loss) | 3 | 1,5 | 1,4 | -4,8 |
EBITDA | 3,3 | 2,5 | 2,6 | 6,5 |
Net profit (loss) | 2,3 | 0,9 | 1,2 | 32,7 |
Cash | 0 | 0 | 0 | 40,4 |
Net income from sale | 127,6 | 126,9 | 134,2 | 5,7 |
Liabilities and provisions for liabilities | 35,9 | 36,4 | 47 | 29 |
Short time liabilities | 31,1 | 32,2 | 42,6 | 32,2 |
Equity capital | 11,2 | 12,1 | 13,3 | 9,8 |
Working assets | 45,9 | 47,5 | 59 | 24,2 |
Operating profit (EBIT) | 3,2 | 2,4 | 2,5 | 6,6 |
Depreciation | 0,1 | 0,1 | 0,1 | 1,9 |
% | % | % | p.p. | |
Profitability of capital | 20,7 | 7,4 | 8,9 | 1,5 |
Equity capital to total assets | 23,9 | 25 | 22,1 | -2,9 |
Gross profit margin | 2,3 | 1,2 | 1,1 | -0,1 |
EBITDA Margin | 2,6 | 2 | 2 | 0 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 89 | 93 | 116 | 23 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane